Skip to main content
Clinical Trials/KCT0007246
KCT0007246
Not yet recruiting
未知

Comparative effects of propofol and remimazolam on US-guided radiofrequency ablation of hepatic neoplasm under monitored anesthesia care

Asan Medical Center0 sites44 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Asan Medical Center
Enrollment
44
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients planning to undergo ultrasound\-guided liver radiofrequency ablation under supervised anesthesia
  • 2\) Adult male and female patients between the ages of 20 and 80
  • 3\) Patients who voluntarily consented in writing to participate in this clinical trial
  • 4\) Patients falling under ASA classification 1\-2

Exclusion Criteria

  • 1\) If the patient does not consent to participate in the study
  • 2\) If you have previously been allergic to propofol or remimazolam
  • 3\) If the modified Allen's test is negative
  • 4\) In case of serious cardiovascular or cerebrovascular disease
  • 5\) If you have serious lung disease
  • 6\) In case of severe liver cirrhosis
  • 7\) Other patients determined by the researcher to be inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials